Article

Coping easier for patients with advance care plans

Author(s):

Advanced care planning--that is, having a living will and a designated health care proxy--helps patients with blood cancers better cope, according to research presented today at the American Society of Hematology's annual meeting in New Orleans.Researchers from the University of Nebraska Medical Center and Fred Hutchinson Cancer Research Center compared the psychological well-being of patients who had advance care planning with those who did not, and although both groups were found to have similar levels of social support, depression and anxiety, and quality of life, they each had different patterns for coping. Patients with ACP were constructive "copers." They were problem-solvers who took advice, planned, and sought moral support or discussed their feelings with others. Patients without ACP, on the other hand, were emotional copers, utilizing techniques like self-blame, denial, and behavioral or mental disengagement.Considering that previous studies found only half of blood cancer patients undergoing a high-risk procedure, such as a stem cell transplant, have advance care planning, this new study can help cancer care providers design interventions that engage more patients in ACP. What may appeal to patients, regardless of coping style, is to highlight the positives and practical importance of ACP while de-emphasizing the emotional aspects, researchers said.Check out the American Cancer Society's advance directives webpage for detailed information on living wills and other important health care-related documents.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Image of doctor with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.
Related Content